Copyright Reports & Markets. All rights reserved.

Global Orphan Drugs Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Orphan Drugs Market Status and Forecast (2017-2028)
      • 1.3.2 Global Orphan Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Orphan Drugs Supply by Company

    • 2.1 Global Orphan Drugs Sales Volume by Company
    • 2.2 Global Orphan Drugs Sales Value by Company
    • 2.3 Global Orphan Drugs Price by Company
    • 2.4 Orphan Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Orphan Drugs Market Status by Type

    • 3.1 Orphan Drugs Type Introduction
      • 3.1.1 Oncology
      • 3.1.2 Pulmonary
      • 3.1.3 Neurology
      • 3.1.4 Hematology
      • 3.1.5 Endocrinology
      • 3.1.6 Cardio-vascular
      • 3.1.7 Metabolic Disorders
      • 3.1.8 Others
    • 3.2 Global Orphan Drugs Market by Type
      • 3.2.1 Global Orphan Drugs Sales Volume by Type (2017-2022)
      • 3.2.2 Global Orphan Drugs Sales Value by Type (2017-2022)
      • 3.2.3 Global Orphan Drugs Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Orphan Drugs Market Status by Application

    • 4.1 Orphan Drugs Segment by Application
      • 4.1.1 Baby and Child
      • 4.1.2 Teenager
      • 4.1.3 Adult
      • 4.1.4 Other
    • 4.2 Global Orphan Drugs Market by Application
      • 4.2.1 Global Orphan Drugs Sales Volume by Application (2017-2022)
      • 4.2.2 Global Orphan Drugs Sales Value by Application (2017-2022)
      • 4.2.3 Global Orphan Drugs Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Orphan Drugs Market Status by Region

    • 5.1 Global Orphan Drugs Market by Region
      • 5.1.1 Global Orphan Drugs Sales Volume by Region
      • 5.1.2 Global Orphan Drugs Sales Value by Region
    • 5.2 North America Orphan Drugs Market Status
    • 5.3 Europe Orphan Drugs Market Status
    • 5.4 Asia Pacific Orphan Drugs Market Status
    • 5.5 Central & South America Orphan Drugs Market Status
    • 5.6 Middle East & Africa Orphan Drugs Market Status

    6 North America Orphan Drugs Market Status

    • 6.1 North America Orphan Drugs Market by Country
      • 6.1.1 North America Orphan Drugs Sales Volume by Country (2017-2022)
      • 6.1.2 North America Orphan Drugs Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Orphan Drugs Market Status

    • 7.1 Europe Orphan Drugs Market by Country
      • 7.1.1 Europe Orphan Drugs Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Orphan Drugs Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Orphan Drugs Market Status

    • 8.1 Asia Pacific Orphan Drugs Market by Country
      • 8.1.1 Asia Pacific Orphan Drugs Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Orphan Drugs Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Orphan Drugs Market Status

    • 9.1 Central & South America Orphan Drugs Market by Country
      • 9.1.1 Central & South America Orphan Drugs Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Orphan Drugs Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Orphan Drugs Market Status

    • 10.1 Middle East & Africa Orphan Drugs Market by Country
      • 10.1.1 Middle East & Africa Orphan Drugs Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Orphan Drugs Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Orphan Drugs Manufacturing Cost Analysis
    • 11.5 Orphan Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Orphan Drugs Sales Channel
      • 11.5.2 Orphan Drugs Distributors
    • 11.6 Orphan Drugs Downstream Major Buyers

    12 Global Orphan Drugs Market Forecast by Type and by Application

    • 12.1 Global Orphan Drugs Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Orphan Drugs Forecast by Type
      • 12.2.1 Global Orphan Drugs Sales Volume Forecast by Type
      • 12.2.2 Global Orphan Drugs Sales Value Forecast by Type
      • 12.2.3 Global Orphan Drugs Price Forecast by Type
    • 12.3 Global Orphan Drugs Forecast by Application
      • 12.3.1 Global Orphan Drugs Sales Volume Forecast by Application
      • 12.3.2 Global Orphan Drugs Sales Value Forecast by Application
      • 12.3.3 Global Orphan Drugs Price Forecast by Application

    13 Global Orphan Drugs Market Forecast by Region/Country

    • 13.1 Global Orphan Drugs Market Forecast by Region (2023-2028)
      • 13.1.1 Global Orphan Drugs Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Orphan Drugs Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vertex Pharmaceuticals
      • 14.1.1 Company Information
      • 14.1.2 Orphan Drugs Product Introduction
      • 14.1.3 Vertex Pharmaceuticals Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Takeda
      • 14.2.1 Company Information
      • 14.2.2 Orphan Drugs Product Introduction
      • 14.2.3 Takeda Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 Orphan Drugs Product Introduction
      • 14.3.3 Sanofi Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Roche
      • 14.4.1 Company Information
      • 14.4.2 Orphan Drugs Product Introduction
      • 14.4.3 Roche Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Pfizer
      • 14.5.1 Company Information
      • 14.5.2 Orphan Drugs Product Introduction
      • 14.5.3 Pfizer Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Novartis
      • 14.6.1 Company Information
      • 14.6.2 Orphan Drugs Product Introduction
      • 14.6.3 Novartis Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Johnson & Johnson
      • 14.7.1 Company Information
      • 14.7.2 Orphan Drugs Product Introduction
      • 14.7.3 Johnson & Johnson Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Eli Lilly
      • 14.8.1 Company Information
      • 14.8.2 Orphan Drugs Product Introduction
      • 14.8.3 Eli Lilly Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Bristol-Myers Squibb
      • 14.9.1 Company Information
      • 14.9.2 Orphan Drugs Product Introduction
      • 14.9.3 Bristol-Myers Squibb Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Biogen
      • 14.10.1 Company Information
      • 14.10.2 Orphan Drugs Product Introduction
      • 14.10.3 Biogen Orphan Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 AstraZeneca
    • 14.12 Amgen
    • 14.13 AbbVie

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Orphan Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Orphan Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Orphan Drugs market is estimated at $ 157600 million in 2021, and projected to grow at a CAGR of 11.5% to $ 337700 million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Orphan Drugs Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Orphan Drugs market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Orphan Drugs Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Orphan Drugs industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Oncology
      Pulmonary
      Cardio-vascular
      Metabolic Disorders
      Others

      Segmented by Application
      Baby and Child
      Teenager
      Adult
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Sanofi
      Roche
      Pfizer
      Novartis
      Johnson & Johnson
      Eli Lilly
      Bristol-Myers Squibb
      Biogen
      AstraZeneca
      Amgen
      AbbVie
      Buy now